These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11850642)

  • 21. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
    Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.
    Pasanisi F; Meredith PA; Reid JL
    Eur J Clin Pharmacol; 1985; 29(1):21-4. PubMed ID: 4054203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
    Glasser SP; Ripa S; Garland WT; Weiss R; Nademanee K; Singh S; Bittar N
    J Clin Pharmacol; 1995 Aug; 35(8):780-4. PubMed ID: 8522634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nisoldipine CC: clinical experience in ischaemic heart disease.
    Melcher A; Dens J; Curry P; Hagel H
    Cardiology; 1997; 88 Suppl 1():17-23; discussion 24-5. PubMed ID: 9118164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus.
    Marques MP; Coelho EB; Dos Santos NA; Geleilete TJ; Lanchote VL
    Eur J Clin Pharmacol; 2002 Dec; 58(9):607-14. PubMed ID: 12483453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steady-state pharmacokinetics of roflumilast and roflumilast N-oxide in patients with mild and moderate liver cirrhosis.
    Hermann R; Nassr N; Lahu G; Péterfai E; Knoerzer D; Herzog R; Zech K; de Mey C
    Clin Pharmacokinet; 2007; 46(5):403-16. PubMed ID: 17465639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics.
    Bailey DG; Arnold JM; Strong HA; Munoz C; Spence JD
    Clin Pharmacol Ther; 1993 Dec; 54(6):589-94. PubMed ID: 8275614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.
    Fodor JG
    Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():873-9. PubMed ID: 9126676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.
    van Harten J; Burggraaf J; van Brummelen P; Breimer DD
    Clin Pharmacokinet; 1989 Jan; 16(1):55-64. PubMed ID: 2706880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and pharmacodynamic interactions during multiple-dose administration of nisoldipine and propranolol.
    Shaw-Stiffel TA; Walker SE; Ogilvie RI; Leenen FH
    Clin Pharmacol Ther; 1994 Jun; 55(6):661-9. PubMed ID: 8004882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Once daily nisoldipine in hypertension: cuff and ambulatory intra-arterial blood pressure.
    Brigden G; Heber M; Caruana M; Lahiri A; Raftery EB
    Eur J Clin Pharmacol; 1989; 37(6):551-4. PubMed ID: 2612549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability in the pharmacokinetics of nisoldipine as caused by differences in liver blood flow response.
    van Harten J; van Brummelen P; Ooms P; Danhof M; Blauw GJ; Breimer DD
    J Clin Pharmacol; 1989 Aug; 29(8):714-21. PubMed ID: 2778091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and tolerability of a new manidipine and delapril fixed oral combination in young and elderly subjects.
    Stockis A; De Bruyn S; Gengler C; Goethals F; Lens S; Poli G; Acerbi D
    Arzneimittelforschung; 2003; 53(8):554-61. PubMed ID: 13677245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.